Reproductive medicine & maternal health

Ferring is a world leader in Assisted Reproductive Technology (ART) for fertility treatment. Ferring’s on-going research efforts in this area strive to meet the growing needs of patients as increasing numbers of couples seek help to conceive. Ferring has developed MENOPUR^® (Highly Purified Menotropin) and REKOVELLE^® (Follitropin Delta) to stimulate the ovaries and DECAPEPTYL^® (gonadotropin releasing hormone agonist) to control the timing of ovary stimulation. #You can refer to the current approved package insert for the respective products in Singapore

A novel peptide (barusiban) is in advanced clinical trials to aid implantation support in ART.

Ferring is using its recombinant DNA technology platform to develop recombinant gonadotropins to complement its human-derived gonadotropin franchise.